je.st
news
Tag: immunogen
ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO
2015-06-02 03:40:01| Biotech - Topix.net
The biggest upside surprise from the American Society for Clinical Oncology meeting in Chicago, which ends Tuesday, probably came from , a beleaguered biotech that came back to life thanks to its antibody drug conjugate mirvetuximab soravtansine, or IMGN853. The drug's objective response rate - the percentage of tumors that shrank - was 53%, which induced several price-target increases and an upgrade to equal weight from Morgan Stanley.
Tags: drugs
scrutiny
surprises
asco
ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2015 Financial Results
2015-04-24 14:30:21| Logistics - Topix.net
ImmunoGen, Inc. , a biotechnology company that develops novel anticancer therapeutics using its ADC technology, today reported financial results for the three-month period ended March 31, 2015 - the third quarter of the Company's 2015 fiscal year. ImmunoGen also provided an update on its product pipeline and financial guidance.
Tags: year
results
reports
financial
Takeda Licenses Rights To Use ImmunoGen, Inc.'s Novel Antibody-Drug Conjugate Technology
2015-04-01 08:41:48| drugdiscoveryonline Home Page
Takeda Pharmaceutical Company Limited and ImmunoGen, Inc., a biotechnology company that develops targeted anticancer therapeutics using its state-of-the-art antibody-drug conjugate (ADC) technology, recently announced that Takeda has licensed exclusive rights to use ImmunoGen’s ADC technology – including ImmunoGen’s new DNA-acting IGN payload agents – to develop and commercialize targeted anticancer therapeutics to up to two undisclosed targets
Tags: rights
technology
licenses
conjugate
Pfizer and ImmunoGen are big market movers
2015-03-24 10:25:40| Food - Topix.net
The drug developer will resume a study of a potential pain treatment with partner Eli Lilly and receive a $200 million payment. The hospital chain said it will spend more than $600 million on separate deals to expand its presence in short-stay surgery and grow in the United Kingdom.
Tags: big
market
movers
pfizer
Pfizer and ImmunoGen are big market movers
2015-03-24 10:06:17| Biotech - Topix.net
The drug developer will resume a study of a potential pain treatment with partner Eli Lilly and receive a $200 million payment. The hospital chain said it will spend more than $600 million on separate deals to expand its presence in short-stay surgery and grow in the United Kingdom.
Tags: big
market
movers
pfizer